Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its ...

TORONTO, ON / ACCESSWIRE / / ProteinQure, a leader in computational peptide design, is proud to announce the addition of two ...

The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad's molecular ...

During Hoda Kotb's last week on the TODAY show, she was surprised by the family of Erin Ludwig, who died due to breast cancer ...

Research shows that patients with advanced breast cancer have higher odds of cardiovascular disease, emphasizing the ...

With the U.S. surgeon general calling for cancer warnings to be added to alcoholic beverage labels, many Americans may be wondering how many, if any, drinks can be consumed safely.

A recent health advisory from the U.S. surgeon general calls for cancer warning labels on alcoholic beverages. What to know ...

Whether AI can assist in cancer detection has been subject to much debate, but now a real-world test with almost 200 ...

AI is as good as clinicians at interpreting mammograms, a real-world study with nearly 500,000 participants in Germany suggests.

The city’s abundance of large health systems has produced a cottage industry of AI-centered medical diagnostics companies ...

Enliven's initial phase 1 data for ELVN-001 in CML shows promising tolerability and activity in heavily pretreated patients. But read why ELVN stock is a Sell.